Featured Research

from universities, journals, and other organizations

Specialists hope to obtain vaccine against Chagas disease in less than three years

Date:
August 28, 2014
Source:
Investigación y Desarrollo
Summary:
The medical development of a vaccine against Chagas disease has been tested in animal models, where it was observed that the disease stopped in 80 percent of cases, scientists now report. Physicians expect similar results from a human control group.

Triatominae, also known as kissing bugs.
Credit: Image courtesy of Investigación y Desarrollo

The medical development has been tested in animal models, where it was observed that the disease stopped in 80 percent of cases; physicians expect similar results from a human control group.

Related Articles


Mexican and American researchers are working on developing a vaccine to stop Chagas disease which is expected to be available for the population within the next three years.

Involved in the scientific work are the Baylor College Medicine, the Center for Research and Advanced Studies, Autonomous University of Yucatán, the laboratory Birmex and the Sabin Vaccine Institute; with funding from the Carlos Slim Health Institute.

So far, the drug that has shown better results against Chagas disease is benznidazole. "However, when administered in newly infected people it has a 60 percent effectiveness at stoping the progression of the disease. Besides, it even manifest certain side effects that make the patient often leave the treatment," says Maria Elena Bottazzi form Baylor College Medicine, who led the project of the therapeutic vaccine, called so because it is still in an experimental phase.

"When we hear the word vaccine we relate it to prevention, in this case of cardiac complications, but this one has demonstrated better tolerance, efficiency time and can be used in conjunction with benznidazole," said the American researcher.

Chagas disease is also called the disease of the poor, as it mainly affects the lower income population in rural areas. It is caused by the parasite Trypanosoma cruzi and transmitted by a blood transfusion or by the bite of the so called "kissing bug" Triatoma infestans.

If the condition is not detected during the first two months, or temporal phase, it passes to a chronic phase, in which the parasites move through the bloodstream into the heart and the digestive system tissues, which will gradually undermine.

Its symptoms can range from dizziness and digestive problems, to abdominal pain, palpitations and difficulty at swallowing; over time cardiac failure will occur by deformation of the myocardium, and in severe cases the abnormality of heart rhythm could cause sudden death.

According to Doctors without Borders in Latin America eight million people currently have Chagas disease and 25 million are at risk of infection, of which 30 percent will develop heart problems; in Mexico it affects 1.1 million people.

The disease can be treated with medication; however, less than one percent of those infected have access to it, plus it requires great care available in its administration.

Maria Elena Bottazzi said that the therapeutic vaccine has been tested in laboratory rodents and dogs infected with T. cruzi and it was observed that the disease stopped in 80 percent and, when administered preemptively, it protects against the parasite in the bloodstream.

The researcher at the Baylor College of Medicine emphasized that its effectiveness is being analyzed in a control group of infected human patients in Mexico, and it is expected that in the next three years all tests to obtain a vaccine will be finalized and it will be made available to the population.

Moreover, Roberto Tapia Conver, director of the Institute of Health Carlos Slim, said that in regard of the parasitology field, "Mexico has much to show but also a lot to learn. The world is still very noble; many social organizations set priorities and how to address them, making their purpose to connect researchers, scientists and vaccine manufacturers to develop and manufacture the products making them available to people, which is the ultimate goal ."


Story Source:

The above story is based on materials provided by Investigación y Desarrollo. Note: Materials may be edited for content and length.


Cite This Page:

Investigación y Desarrollo. "Specialists hope to obtain vaccine against Chagas disease in less than three years." ScienceDaily. ScienceDaily, 28 August 2014. <www.sciencedaily.com/releases/2014/08/140828090158.htm>.
Investigación y Desarrollo. (2014, August 28). Specialists hope to obtain vaccine against Chagas disease in less than three years. ScienceDaily. Retrieved November 1, 2014 from www.sciencedaily.com/releases/2014/08/140828090158.htm
Investigación y Desarrollo. "Specialists hope to obtain vaccine against Chagas disease in less than three years." ScienceDaily. www.sciencedaily.com/releases/2014/08/140828090158.htm (accessed November 1, 2014).

Share This



More Health & Medicine News

Saturday, November 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) — The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) — The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) — New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) — Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins